As weight-loss injections surge in popularity, a national debate is unfolding in the United Kingdom: are we embracing a medical revolution, or sleepwalking into a cultural crisis?
Originally developed for type 2 diabetes, drugs like Ozempic, Wegovy, and Mounjaro are now widely used for weight loss. These GLP-1 receptor agonists suppress appetite, and for many, they’ve delivered dramatic results. But with demand skyrocketing, questions are mounting.
In Greater Manchester, the UK government is backing a £40 million, five-year trial offering up to 3,000 unemployed people with obesity access to weight-loss jabs. Health Secretary Wes Streeting defended the move, calling it a proactive approach to preventative health.
“There’s a lot of evidence already that these jabs, combined with changes to diet and exercise, can help people reduce their weight but also prevent cardiovascular disease and diabetes, which is game-changing,” he said.
But concerns persist. Streeting also warned against creating a "dependency culture." Medical professionals are raising alarms over side effects—nausea, fatigue, and digestive issues—and the unknowns around long-term use. Off-label prescribing and growing black-market access online are also fuelling unease.
Beyond the medical debate lies a cultural one: Are we beginning to medicalise body image? Could society come to expect weight loss from a syringe instead of sustainable lifestyle changes.
Source: Independent (UK)
Bd-pratidin English/Jisan
